5Anthonisen NR,Skeans MA,Wise RA,et al.The effects of a smoking cessation intervention on 14.5-year mortality:a randomized,clinical trial.Ann Intern Med,2005,142(4):233-239.
6Campos MA,Wanner A.The rationale for pharmacologic therapy in stable chronic obstructive pulmonary disease.Am J Med Sci,2005,329(4):188-189.
7Maltais F,Hamilton A,Marciniuk D,et al.Improvements in symptom-limited exercise performance over 8 h with once-dailytiotropium in patients with COPD.Chest,2005,128:1168-1178.
8Niewoehner DE,Erbland ML,Deupree RH,et al.Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease.N Engl J Med,1999,340(25):1941-1947.
9Barnes PJ.Potential novel therapies for chronic obstructive pulmonary disease.Novartis Found Symp,2001,234:255-267.
10Nagaya N,Itoh T,Murakami S,et al.Treatment of caehexia with ghrelin in patents with COPD.Chest,2005,128:1187-1193.
